Resume

INTERIM MANAGEMENT PROJEcts (Selected)

07/2017 – 03/2019
Synlab Suisse SA (Routine medical diagnostics)
650 employees CH, > 20.000 global |
Commercial Director CH, Board Member, Location Lucerne

• Report line: CEO
• Achievements: Topline +5% EBITDA +1,2%, reorg Sales force completed, set-up contract management completed
• Responsibility: 150 mCHF Schweiz, PnL, 40 employees
• Primary goals: Management and restructuring Sales force, turnaround, introduction of compliance management in sales, introduction of KPI, introduction of Sales Funnel management; Digitization of services

09/2016 – 05/2017
McKesson Europe AG, formerly Celesio AG (Pharmaceutical Industry)
35.000 employees Europa |
European Head of Bx, Director´s Board Member, Location Stuttgart

• Report line: Director of Procurement
• Achievements: Topline +1.000%, EBITDA +1.000%, reorg Bx completed
• Responsibility: 17 b€ (Matrix), PnL, 5 employees
• Primary goals: Management and restructuring of the Bx division, increasing sales and earnings in new business areas, leading the countries in dotted lines, digitizing the business model, implementing big data applications, introducing new hospital care

05/2016 – 08/2016
Merck Group (Pharmaceutical Industry)
51.000 employees global |
Global Key Account Director Fertility, Location Darmstadt

• Report line: Vice President Global Fertility
• Achievements: Evaluation and reorg completed
• Responsibility: 350 m€ global (Matrix), Turnover
• Primary goals: Evaluation of the global customer, pricing and reimbursement landscape, introduction of the KAM system, definition of interfaces to the retail sector, distribution of roles and responsibilities, redefinition of a KAM-oriented CRM system

10/2013-10/2014
ThermoFisher Scientific, Phadia Deutschland GmbH (Diagnostics)
5.000 employees Germany | Commercial Director, Board Member

• Report line: Managing Director DACH
• Achievements: Topline +20%, EBITDA +3%, reorg and turnaround completed
• Responsibility: 50 m€ D, PnL, 30 employees
• Primary goals: Reorg of post M & A integration, increase in sales and EBIT and pricing, restructuring and hybridization of field and office staff, reduction of silos, implementation of CRM, introduction of KPI systems, in-depth discussions with the works council, management of technical operations

09/2011 – 05/2012
Vifor Pharma Espana (Pharmaceutical Industry)
2.500 employees global | Chief Restructuring Officer, Board Member

• Report line: Senior Vice President SEMEA
• Achievements: Topline +3%, EBITDA +2%, all streams completed
• Responsibility: 80 m€ (Matrix), PnL, 150 employees

Primary goals: Post M & A integration, stabilize sales/margins, New Business Development, multi stream management, Sales/Lingual/Steering/Process Excellence, set-up KAM, Introducing KPI Systems, introducing CRM / CRM excellence, cultural change from paternalistic to corporate structures, reorg operations